Leerink Partnrs Issues Optimistic Outlook for ARDT Earnings

Ardent Health Partners, LLC (NYSE:ARDT) – Stock analysts at Leerink Partnrs increased their Q4 2025 EPS estimates for Ardent Health Partners in a research note issued to investors on Tuesday, April 1st. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings of $0.68 per share for the quarter, up from their prior estimate of $0.61. The consensus estimate for Ardent Health Partners’ current full-year earnings is $1.23 per share. Leerink Partnrs also issued estimates for Ardent Health Partners’ Q1 2026 earnings at $0.38 EPS, Q2 2026 earnings at $0.57 EPS, Q3 2026 earnings at $0.46 EPS and Q4 2026 earnings at $0.66 EPS.

A number of other analysts also recently commented on ARDT. Stephens reiterated an “overweight” rating and issued a $22.00 price objective on shares of Ardent Health Partners in a research report on Tuesday. Truist Financial decreased their price target on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $20.00 price objective on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Royal Bank of Canada decreased their target price on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 4th. Finally, Morgan Stanley dropped their price target on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a research report on Tuesday, January 21st. Two research analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $21.18.

Ardent Health Partners Price Performance

ARDT stock opened at $12.22 on Thursday. Ardent Health Partners has a twelve month low of $12.13 and a twelve month high of $20.72. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The business’s 50-day simple moving average is $14.25 and its 200 day simple moving average is $16.07.

Ardent Health Partners (NYSE:ARDT) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.31. The company had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.48 billion.

Institutional Trading of Ardent Health Partners

Several large investors have recently added to or reduced their stakes in ARDT. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Ardent Health Partners during the fourth quarter worth $27,000. US Bancorp DE acquired a new position in Ardent Health Partners during the 4th quarter worth about $31,000. R Squared Ltd bought a new stake in Ardent Health Partners during the 4th quarter worth about $37,000. BNP Paribas Financial Markets acquired a new stake in Ardent Health Partners in the 3rd quarter valued at about $42,000. Finally, New York State Common Retirement Fund acquired a new stake in Ardent Health Partners in the 4th quarter valued at about $48,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.